Ocugen Inc
OCGN·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$0.93
Today
-2.6%
YTD
-28.8%
About
Ocugen, Inc is a locally operating healthcare company that was founded in 2013 and based in Pennsylvania. It develops and takes to market therapies for rare eye diseases. In 2020, the company presented at a key Life Sciences & MedTech summit. It is listed on the NASDAQ CM under the ticker OCGN. Keep track of the OCGN price chart at eToro.
Price chart
Closing price history for OCGN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-4.08
P/S (TTM)76.91
P/B (TTM)-21.30
Market cap$352.67M
Cap tierSmall-cap
Industry avg P/E-7.40
Profitability
Gross margin36.98%
EBIT margin-1504.43%
Net margin-1671.84%
ROE-660.00%
ROA-92.03%
Earnings & Revenue
Revenue (TTM)$4.58M
Revenue growth (1Y)-3.7%
EPS (TTM)-$0.25
Free cash flow$-61.02M
Total debt$87.99M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.53
Employees116
Next earnings5 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.